Blood eosinophil count and exacerbation risk in patients with COPD

Marjan Kerkhof; Samatha Sonnappa; Dirkje S Postma; Guy  Brusselle; Alvar Agusti; Antonio  Anzueto; Rupert Jones; Alberto Papi; Ian D. Pavord; Emilio Pizzichini; Todor A Popov; Nicolas Roche; Dermot Ryan; Mike Thomas; Claus Vogelmeier; Alison Chisholm; Daryl Freeman; Mona Bafadhel; Elizabeth V Hillyer; David B Price

doi:10.1183/13993003.00761-2017

Blood eosinophil count and exacerbation risk in patients with COPD

Marjan Kerkhof, Samatha Sonnappa, Dirkje S Postma, Guy Brusselle, Alvar Agusti, Antonio Anzueto, Rupert Jones, Alberto Papi, Ian D. Pavord, Emilio Pizzichini, Todor A Popov, Nicolas Roche, Dermot Ryan, Mike Thomas, Claus Vogelmeier, Alison Chisholm, Daryl Freeman, Mona Bafadhel, Elizabeth V Hillyer, David B Price

Research output: Contribution to journal › Letter › peer-review

59 Citations (Scopus)

11 Downloads (Pure)

Abstract

Blood eosinophil count may serve as a biomarker of exacerbation risk in subgroups of patients with COPD http://ow.ly/6tm530cEAeO

Original language	English
Article number	1700761
Journal	European Respiratory Journal
Volume	50
Issue number	1
DOIs	https://doi.org/10.1183/13993003.00761-2017
Publication status	Published - 1 Jul 2017

Access to Document

10.1183/13993003.00761-2017Licence: Unspecified

Accepted Manuscript
This is an author-submitted, peer-reviewed version of a manuscript that has been accepted for publication in the European Respiratory Journal, prior to copy-editing, formatting and typesetting. This version of the manuscript may not be duplicated or reproduced without prior permission from the copyright owner, the European Respiratory Society. The publisher is not responsible or liable for any errors or omissions in this version of the manuscript or in any version derived from it by any other parties. The final, copy-edited, published article, which is the version of record, is available without a subscription 18 months after the date of issue publication.
Accepted author manuscript, 29.8 KBLicence: Other

Cite this

Kerkhof, M., Sonnappa, S., Postma, D. S., Brusselle, G., Agusti, A., Anzueto, A., Jones, R., Papi, A., Pavord, I. D., Pizzichini, E., Popov, T. A., Roche, N., Ryan, D., Thomas, M., Vogelmeier, C., Chisholm, A., Freeman, D., Bafadhel, M., Hillyer, E. V., & Price, D. B. (2017). Blood eosinophil count and exacerbation risk in patients with COPD. European Respiratory Journal, 50(1), [1700761]. https://doi.org/10.1183/13993003.00761-2017

Kerkhof, M, Sonnappa, S, Postma, DS, Brusselle, G, Agusti, A, Anzueto, A, Jones, R, Papi, A, Pavord, ID, Pizzichini, E, Popov, TA, Roche, N, Ryan, D, Thomas, M, Vogelmeier, C, Chisholm, A, Freeman, D, Bafadhel, M, Hillyer, EV & Price, DB 2017, 'Blood eosinophil count and exacerbation risk in patients with COPD', European Respiratory Journal, vol. 50, no. 1, 1700761. https://doi.org/10.1183/13993003.00761-2017

@article{c345d003feff4055bfaa608c524f57f8,

title = "Blood eosinophil count and exacerbation risk in patients with COPD",

abstract = "Blood eosinophil count may serve as a biomarker of exacerbation risk in subgroups of patients with COPD http://ow.ly/6tm530cEAeO",

author = "Marjan Kerkhof and Samatha Sonnappa and Postma, {Dirkje S} and Guy Brusselle and Alvar Agusti and Antonio Anzueto and Rupert Jones and Alberto Papi and Pavord, {Ian D.} and Emilio Pizzichini and Popov, {Todor A} and Nicolas Roche and Dermot Ryan and Mike Thomas and Claus Vogelmeier and Alison Chisholm and Daryl Freeman and Mona Bafadhel and Hillyer, {Elizabeth V} and Price, {David B}",

note = "Support statement: support was provided by the Respiratory Effectiveness Group (REG-RES1306). Funding information for this article has been deposited with the Crossref Funder Registry.",

year = "2017",

month = jul,

day = "1",

doi = "10.1183/13993003.00761-2017",

language = "English",

volume = "50",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "1",

}

TY - JOUR

T1 - Blood eosinophil count and exacerbation risk in patients with COPD

AU - Kerkhof, Marjan

AU - Sonnappa, Samatha

AU - Postma, Dirkje S

AU - Brusselle, Guy

AU - Agusti, Alvar

AU - Anzueto, Antonio

AU - Jones, Rupert

AU - Papi, Alberto

AU - Pavord, Ian D.

AU - Pizzichini, Emilio

AU - Popov, Todor A

AU - Roche, Nicolas

AU - Ryan, Dermot

AU - Thomas, Mike

AU - Vogelmeier, Claus

AU - Chisholm, Alison

AU - Freeman, Daryl

AU - Bafadhel, Mona

AU - Hillyer, Elizabeth V

AU - Price, David B

N1 - Support statement: support was provided by the Respiratory Effectiveness Group (REG-RES1306). Funding information for this article has been deposited with the Crossref Funder Registry.

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Blood eosinophil count may serve as a biomarker of exacerbation risk in subgroups of patients with COPD http://ow.ly/6tm530cEAeO

AB - Blood eosinophil count may serve as a biomarker of exacerbation risk in subgroups of patients with COPD http://ow.ly/6tm530cEAeO

U2 - 10.1183/13993003.00761-2017

DO - 10.1183/13993003.00761-2017

M3 - Letter

VL - 50

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 1

M1 - 1700761

ER -

Blood eosinophil count and exacerbation risk in patients with COPD

Abstract

Access to Document

Fingerprint

Cite this